Nearly half of women seeking menopause help already at serious clinical risk, new Australian report reveals

Metluma

• New data from 1,468 women shows severe menopause depression risk is closely tied to isolation, exhaustion, brain fog and collapsing confidence, not just low mood.
• Isolation was closely aligned to depression risk level with 12.3% of women in the low-risk group reported feeling isolated at a moderate-or-higher level. That figure surged to 94.0% among women in the severe-risk category.
• The report also found that 43% of participants triggered at least one clinical red flag at baseline (referral to a doctor within 24-48 hours)
   
• New guidelines proposed by experts around menopause stage vs menopause age to help women and healthcare professionals close the gap on clinical guidance and outcomes

New data from 1,468 Australian women suggests too many are reaching breaking point before receiving menopause support.

SYDNEY, Australia, Thursday 7th May 2026 - Nearly half of women seeking help for menopause symptoms are already experiencing clinically significant distress by the time they ask for support, according to a new national benchmark report released today by Metluma.

The landmark 2026 Australian Menopause Experience Report, based on insights from 1,468 women using Metluma’s UMA40 assessment tool, found 43% triggered at least one clinical red flag at baseline (referral to a doctor within 24-48 hours), with more than one in five presenting with multiple red flags linked to more complex symptom burden.

The findings paint a stark picture of menopause being recognised too late, with many women arriving already exhausted, mentally depleted and struggling to function across work, relationships and daily life.

Far from being limited to hot flushes, above and beyond high-risk symptoms such as heart palpitations, debilitating migraines and dizziness, the most common moderate-or-above symptoms were:

• Fatigue (75.2%)

• Poor concentration (64.6%)

• Low libido (62.9%)

• Forgetfulness (59.6%)

• Feeling overwhelmed (59.1%)

• Sleep disturbance (58.5%)

• Anxiety (54.2%)

Metluma's Chief Medical Officer Dr Nicole Avard said the report exposes how often menopause is still misunderstood, minimised or mistaken for unrelated problems.

“Too many women are being told they are stressed, burnt out, anxious or simply not coping, when menopause may be sitting at the centre of it all,” Dr Avard said.

“By the time many seek help, they are not mildly inconvenienced. They are depleted, distressed and wondering what has happened to them.”

“This is not a niche issue. It is affecting women’s health, confidence, relationships, careers and economic participation.”

The report found menopause symptoms are colliding with women’s highest-responsibility years.

Poor concentration peaked among women aged 40 to 44, often a life stage associated with career progression, leadership pressure and caregiving load. Work (30.4%) and primary relationships (31.1%) were the areas of life most commonly reported as impacted.

CEO and Co-founder of Metluma, Georgie Drury said menopause remains one of Australia’s most underestimated productivity and wellbeing issues.

“For many women, this is happening while they are leading teams, raising families, caring for others and carrying peak responsibility,” Ms Drury said.

“When support is absent, the costs do not vanish. They show up in absenteeism, disengagement, relationship strain, lost confidence and women stepping back at the very point they should be thriving.”

The report also found menopause stage was a stronger predictor of symptoms than age alone, with 77.8% of symptoms varying significantly by stage, challenging simplistic age-based assumptions about when menopause starts and ends, prompting a call by experts to update guidelines to consider this crucial aspect.

There was also encouraging evidence that support works.

Among women who completed progress reviews with Metluma, 73% improved their overall symptom burden, while 78% improved emotional and psychological symptoms.

One Metluma patient, senior executive Michelle, 48, spent over six months identifying what she was experiencing.

“All I wanted to do was quit my job and bake sourdough. I couldn’t concentrate, I was exhausted, anxious and snapping at people I love,” she said.

“Once I understood what was happening, everything changed. Having language for it and proper support gave me my confidence back.”

Dr Avard said that whilst awareness around perimenopause and menopause had increased following the Senate inquiry last year, there are still major gaps that women are falling through as highlighted in this latest report.

-ENDS-

ABOUT METLUMA

Metluma is on a mission to help more women press play on menopause, their way. We keep women moving forward.

Co-Founded by Georgie Drury, Dr Nicole Avard and Jarrah Eddy, Metluma provides a doctor-led collaborative care approach to perimenopause and menopause. Every element is grounded in evidence-based healthcare through ongoing collaborative research with some of Australia’s top Universities.

Metluma believes wellbeing is not a destination you arrive at, unpack your bag and stay at indefinitely. By walking alongside women in their ever-changing health journey the personalised programs ensure the best possible outcomes for each person.

Their personalised, practical and non-judgemental offering combines three proven elements -  expert information, health coaching and 24/7 access through their Smart Health Community app.

Visit www.metluma.com to learn more.

For any questions in relation to this release or to discuss interviews, please contact:

Nicole Papoutsis

[email protected]

0422 418 099